Search | Page 11 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes

    ... Associated Drug(s):  Cyclophosphamide Cyclosporine Fludarabine ... Intervention:  Drug: Cyclophosphamide Given IV Other Names: (-)-Cyclophosphamide 2H-1,3,2-Oxazaphosphorine, ...

    Clinical Trial last updated 04/27/2016 - 1:17pm.

  2. Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia

    ... Antithymocyte Globulin Cyclophosphamide Fludarabine ... to -2 from transplant. Other Name: Fludara Drug: Cyclophosphamide Cyclophosphamide 50 mg/kg IV over 2 hours on day -7 from ...

    Clinical Trial last updated 04/25/2016 - 10:59am.

  3. Pilot Study of Lupron to Improve Immune Function After Allogeneic Bone Marrow Transplantation

    ... Associated Drug(s):  Cyclophosphamide Phase:  ... with a maximum of 3 mCi On day + 28 (+/- 5 days) Drug: Cyclophosphamide Cyclophosphamide: 60 mg/kg IV on days -4 and -3 (for Adults & ...

    Clinical Trial last updated 04/28/2016 - 11:14am.

  4. CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

    ... Alemtuzumab Cyclophosphamide Fludarabine ... with Thiotepa metabolism. Other Name: Thioplex Drug: Cyclophosphamide Cyclophosphamide (Cytoxan) should be infused over one hour. ...

    Clinical Trial last updated 05/03/2016 - 10:47am.

  5. Personalized Natural Killer (NK) Cell Therapy in Cord Blood Transplantation (CBT)

    ... with CD20+ malignancies. Other Name: Rituxan Drug: Cyclophosphamide 50 mg/kg by vein on Day -6. Other Names: ... Alkeran Drug: Mesna Mesna by vein on Day -6, after cyclophosphamide to help lower the risk of side effects to the bladder. ...

    Clinical Trial last updated 06/06/2016 - 10:28am.

  6. Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers

    ... Associated Drug(s):  Cyclophosphamide Cyclosporine Fludarabine ... Vincristine Vincristine:0.4 mg/m2/day CIV, days 1-4 Drug: Cyclophosphamide Cyclophosphamide, 750 mg/m2/day IV, day 5 Biological: T-Rapa ...

    Clinical Trial last updated 04/28/2016 - 11:28am.

  7. Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies

    ... Associated Drug(s):  Cyclophosphamide Fludarabine Mycophenolate ... Names: Allogeneic Lymphocytes ALLOLYMPH Drug: Cyclophosphamide Given IV Other ...

    Clinical Trial last updated 05/03/2016 - 10:51am.

  8. Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies

    ... Associated Drug(s):  Cyclophosphamide Gender:  ... Names: irradiation radiotherapy therapy, radiation Drug: cyclophosphamide Given IV over 1-2 hours every 24 hours on days -3 to ...

    Clinical Trial last updated 05/03/2016 - 11:29am.

  9. Intra-Osseous Co-Transplant of UCB and hMSC

    ... Associated Drug(s):  Cyclophosphamide Cyclosporine Fludarabine ... Intervention:  Drug: cyclophosphamide All patients will receive a single IV dose of 50 mg/kg of ...

    Clinical Trial last updated 05/02/2016 - 11:15am.

  10. RIC Transplant Using Haplo Donors

    ... Associated Drug(s):  Cyclophosphamide Phase:  ... melphalan (140mg/m2) given one time on Day -1. Drug: Cyclophosphamide cyclophosphamide (50mg/kg) given every day starting on ...

    Clinical Trial last updated 04/29/2016 - 10:52am.